Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower ...

Talazoparib plus enzalutamide boosts overall survival in metastatic castration-resistant prostate cancer, with HRR-deficient ...

Despite the disappointing results in China and a challenging market, L'Oréal managed to grow in all product divisions. Read ...

Gooding girls basketball advanced to the state tournament for the first time since 2006 on Wednesday night. Check our website ...

SIP inflows have consistently stayed above Rs 26,000 crore for the second month, demonstrating investor confidence despite ...